CRON Cronos Group Inc

$0.06 (0.98%)

CRON Stock Analysis Overview

What this means: InvestorsObserver gives Cronos Group Inc (CRON) an overall rank of 31, which is below average. Cronos Group Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full CRON report

Cronos Group Inc (CRON) Analyst Forecast

Next 12 months ➝Current Price$6.1752-week High$15.8552-week Low$4.00MEAN$6.61+7.15%HIGH$10.00+62.07%LOW$4.30-30.31%
  • Last Price$6.17
  • Previous Close$6.11
  • Change $0.06
  • Open$6.13
  • Volume2,169,379
  • Avg. Volume (100-day)6,359,449
  • Market Capitalization$2B
  • Days Range $6.08 - $6.24
  • 52-week Range $4.00 - $15.85
  • Dividend Yield
  • Ex. Dividend Date
  • P-E2.4
  • EPS1.23
  • Earnings Date08/13/2020
  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • Avg. Analyst Rec.
  • Beta2.099
  • PEG Ratio
  • Volatility0.68
  • Average True Range0.07
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany.